European Heart Journal - My Cardio Interview: Patrick Serruys & Ulf Landmesser on drug scaffolds

submitted by: OxfordJournals

Patrick Serruys in conversation with Ulf Landmesser:
Biodegradable drug eluting scaffold - the 4th revolution

European Heart Journal - My Cardio Interview: Marc Pfeffer & Thomas Luscher

submitted by: OxfordJournals

Marc Pfeffer in conversation with Thomas Lüscher:
Cardiovascular drugs and cancer: myth or reality?

European Heart Journal - My Cardio Interview: Andreas Zeiher & Ulf Landmesser on stem cells

submitted by: OxfordJournals

Andreas Zeiher in conversation with Ulf Landmesser:
Stem cells - An Update

European Heart Journal - My Cardio Interview: Christian Muller & Thomas Luscher

submitted by: OxfordJournals

Christian Müller in conversation with Thomas Lüscher:
High sensitive troponin and other biomarkers in ACS

European Heart Journal - My Cardio Interview: Volkmar Falk & Thomas Luscher on Surgical Intervention

submitted by: OxfordJournals

Volkmar Falk in conversation with Thomas Lüscher:
Surgical Intervention

European Heart Journal - My Cardio Interview: Alec Vahanian & Thomas Luscher on TAVI

submitted by: OxfordJournals

Alec Vahanian in conversation with Thomas Lüscher:
TAVI: For lower risk patients?

European Heart Journal - My Cardio Interview: Helmut Baumgartner & Ulf Landmesser on GUCH

submitted by: OxfordJournals

Helmut Baumgartner in conversation with Ulf Landmesser:
GUCH : The new ESC Guidelines

European Heart Journal - My Cardio Interview: Domenico Corrado & Chris Schmied on Marathon running

submitted by: OxfordJournals

Domenico Corrado in conversation with Chris Schmied:
The Marathon-run - a supraphysiological strain

European Heart Journal - My Cardio Interview: Colin Baigent & Thomas Luscher on SHARP

submitted by: OxfordJournals

Colin Baigent in conversation with Thomas L&#252scher:
SHARP: Cholesterol-lowering effective in kidney disease

European Heart Journal - My Cardio Interview: John P. Kastelein & Ulf Landmesser

submitted by: OxfordJournals

John P. Kastelein in conversation with Ulf Landmesser:
Epidemiology of HDL